skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 244  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Relationship between Hyperuricemia and Echocardiographic Parameters in Patients with Chronic Atrial Fibrillation
Material Type:
Article
Add to My Research

The Relationship between Hyperuricemia and Echocardiographic Parameters in Patients with Chronic Atrial Fibrillation

Journal of clinical medicine, 2023-07, Vol.12 (15), p.5034 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm12155034 ;PMID: 37568436

Full text available

2
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials
Material Type:
Article
Add to My Research

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials

Circulation (New York, N.Y.), 2015-04, Vol.131 (17), p.1486-1494 [Peer Reviewed Journal]

2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.013760 ;PMID: 25810334

Full text available

3
The day after tomorrow: echocardiography laboratories after the COVID-19 outbreak
Material Type:
Article
Add to My Research

The day after tomorrow: echocardiography laboratories after the COVID-19 outbreak

European Heart Journal - Cardiovascular Imaging, 2020-09, Vol.21 (9), p.1057-1057 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020 ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;ISSN: 2047-2404 ;EISSN: 2047-2412 ;DOI: 10.1093/ehjci/jeaa207 ;PMID: 32734283

Digital Resources/Online E-Resources

4
Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm
Material Type:
Article
Add to My Research

Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm

Drugs in Context, 2021, Vol.10, p.1-3 [Peer Reviewed Journal]

Copyright © 2021 Garcia-Moll X, Barrios V, Franch-Nadal J. 2021 ;ISSN: 1745-1981 ;ISSN: 1740-4398 ;EISSN: 1740-4398 ;DOI: 10.7573/dic.2021-6-3 ;PMID: 34466139

Full text available

5
Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease
Material Type:
Article
Add to My Research

Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease

Hypertension research, 2020-07, Vol.43 (7), p.696-704 [Peer Reviewed Journal]

The Japanese Society of Hypertension 2020. ;ISSN: 0916-9636 ;EISSN: 1348-4214 ;DOI: 10.1038/s41440-020-0462-9 ;PMID: 32398795

Full text available

6
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis
Material Type:
Article
Add to My Research

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis

Circulation (New York, N.Y.), 2009-12, Vol.120 (22), p.2188-2196 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.109.849117 ;PMID: 19917888 ;CODEN: CIRCAZ

Full text available

7
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
Material Type:
Article
Add to My Research

Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study

Journal of clinical medicine, 2023-04, Vol.12 (9), p.3187 [Peer Reviewed Journal]

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm12093187 ;PMID: 37176627

Full text available

8
Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
Material Type:
Article
Add to My Research

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?

ESC Heart Failure, 2019-12, Vol.6 (6), p.1334-1335 [Peer Reviewed Journal]

2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.12522 ;PMID: 31876114

Full text available

9
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study
Material Type:
Article
Add to My Research

Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

Medicina (Kaunas, Lithuania), 2023-10, Vol.59 (10), p.1846 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1648-9144 ;ISSN: 1010-660X ;EISSN: 1648-9144 ;DOI: 10.3390/medicina59101846

Full text available

10
Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach
Material Type:
Article
Add to My Research

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach

Future cardiology, 2022-09, Vol.18 (9), p.743-754 [Peer Reviewed Journal]

2022 The Authors ;ISSN: 1479-6678 ;EISSN: 1744-8298 ;DOI: 10.2217/fca-2022-0044

Full text available

11
Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain
Material Type:
Article
Add to My Research

Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain

Journal of clinical medicine, 2023-02, Vol.12 (3), p.1224 [Peer Reviewed Journal]

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm12031224 ;PMID: 36769872

Full text available

12
Perception of Patients Regarding Burdens and Benefits of Vitamin K Antagonists Among Patients with Nonvalvular Atrial Fibrillation
Material Type:
Article
Add to My Research

Perception of Patients Regarding Burdens and Benefits of Vitamin K Antagonists Among Patients with Nonvalvular Atrial Fibrillation

Cardiovascular & hematological agents in medicinal chemistry, 2018, Vol.16 (2), p.106-113 [Peer Reviewed Journal]

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. ;Copyright Bentham Science Nov 2018 ;ISSN: 1871-5257 ;EISSN: 1875-6182 ;DOI: 10.2174/1871525716666180608075834 ;PMID: 29879893

Full text available

13
Diagnosis and treatment of patients with ANOCA
Material Type:
Article
Add to My Research

Diagnosis and treatment of patients with ANOCA

REC, Interventional cardiology (Internet. English ed.), 2024-05, Vol.6 (2), p.106-116 [Peer Reviewed Journal]

ISSN: 2604-7322 ;EISSN: 2604-7322 ;DOI: 10.24875/RECICE.M23000420

Full text available

14
Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention
Material Type:
Article
Add to My Research

Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention

Journal of clinical medicine, 2024-01, Vol.13 (2), p.314 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm13020314 ;PMID: 38256448

Full text available

15
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Material Type:
Article
Add to My Research

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

Journal of comparative effectiveness research, 2023-03, Vol.12 (3), p.e220049-e220049 [Peer Reviewed Journal]

2023 Becaris Publishing Ltd 2023 ;ISSN: 2042-6305 ;EISSN: 2042-6313 ;DOI: 10.57264/cer-2022-0049 ;PMID: 36749006

Full text available

16
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain
Material Type:
Article
Add to My Research

Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain

Frontiers in cardiovascular medicine, 2024, Vol.11, p.1324537-1324537 [Peer Reviewed Journal]

2024 Martínez López, Gómez Cerezo, Gámez, Egocheaga Cabello, Castellanos, Campuzano Ruiz, Barrios, Pallarés-Carratalá, Rodríguez, Morant Talamante, Parrondo and Mostaza. ;2024 Martínez López, Gómez Cerezo, Gámez, Egocheaga Cabello, Castellanos, Campuzano Ruiz, Barrios, Pallarés-Carratalá, Rodríguez, Morant Talamante, Parrondo and Mostaza. 2024 Martínez López, Gómez Cerezo, Gámez, Egocheaga Cabello, Castellanos, Campuzano Ruiz, Barrios, Pallarés-Carratalá, Rodríguez, Morant Talamante, Parrondo and Mostaza ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1324537 ;PMID: 38481954

Full text available

17
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry
Material Type:
Article
Add to My Research

Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

ESC Heart Failure, 2022-12, Vol.9 (6), p.4209-4218 [Peer Reviewed Journal]

2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2055-5822 ;EISSN: 2055-5822 ;DOI: 10.1002/ehf2.14014 ;PMID: 36106548

Full text available

18
Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes

Journal of clinical medicine, 2021-10, Vol.10 (20), p.4634 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm10204634 ;PMID: 34682756

Full text available

19
Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy
Material Type:
Article
Add to My Research

Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy

Current cardiology reviews, 2021, Vol.17 (3), p.294-305 [Peer Reviewed Journal]

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. ;Copyright Bentham Science May 2021 ;2021 Bentham Science Publishers 2021 ;ISSN: 1573-403X ;EISSN: 1875-6557 ;DOI: 10.2174/1573403X16999200817111150 ;PMID: 32811401

Full text available

20
Rosuvastatin and Diabetes: When the Evidences Talk
Material Type:
Article
Add to My Research

Rosuvastatin and Diabetes: When the Evidences Talk

Cardiovascular & hematological agents in medicinal chemistry, 2013-06, Vol.11 (2), p.115-124 [Peer Reviewed Journal]

ISSN: 1871-5257 ;EISSN: 1875-6182 ;DOI: 10.2174/1871525711311020007 ;PMID: 23094943

Full text available

Results 1 - 20 of 244  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (203)

Refine My Results

Creation Date 

From To
  1. Before 2004  (25)
  2. 2004 To 2008  (53)
  3. 2009 To 2013  (75)
  4. 2014 To 2019  (29)
  5. After 2019  (63)
  6. More options open sub menu

Resource Type 

  1. Articles  (243)
  2. Web Resources  (1)
  3. More options open sub menu

Language 

  1. English  (209)
  2. Spanish  (23)
  3. Portuguese  (9)
  4. French  (4)
  5. Russian  (3)
  6. Japanese  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait